Prostaglandins and Other Lipid Mediators : Impact Factor & More
eISSN: 2212-196XpISSN: 1098-8823
Share this on:
Key Metrics
CiteScore 
5.6
Impact Factor
< 5
SJR
Q3Physiology
SNIP
0.86
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Prostaglandins and Other Lipid Mediators
Prostaglandins and Other Lipid Mediators Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | ELSEVIER SCIENCE INC |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1972 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Prostaglandins and Other Lipid Mediators ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Prostaglandins and Other Lipid Mediators
Thromboxane A2 synthase is an off target of the CES1 small-molecule inhibitor WWL113.
- 1 Jun 2026
- Prostaglandins & other lipid mediators
Exploring lipid metabolism reprogramming in meningiomas through lipidomics of matched clinical specimens.
- 1 Jun 2026
- Prostaglandins & other lipid mediators
Elicitation of allergic airway inflammation modulates the cough response via increased prostaglandin I₂ in ovalbumin-sensitized guinea pigs.
- 1 Jun 2026
- Prostaglandins & other lipid mediators
Guggulsterone-Mediated Selective Modulation of Nuclear Receptors: Implications for FXR-PXR Signaling and Hepatic Metabolic Homeostasis.
- 14 May 2026
- Prostaglandins & other lipid mediators
Effect of essential fatty acids (EFAs) and their metabolites on the growth suppressive action of anti-cancer drug doxorubicin on neuro- and glioblastoma cells in vitro.
- 13 May 2026
- Prostaglandins & other lipid mediators
Pharmacological modulation of NF-κB-dependent COX-2/PGE₂ signaling influences inflammatory lesion development during Leishmania mexicana infection.
- 22 Apr 2026
- Prostaglandins & other lipid mediators
Thromboxane A2 synthase is an off target of the CES1 small-molecule inhibitor WWL113.
- 1 Jun 2026
- Prostaglandins & other lipid mediators
Exploring lipid metabolism reprogramming in meningiomas through lipidomics of matched clinical specimens.
- 1 Jun 2026
- Prostaglandins & other lipid mediators
Elicitation of allergic airway inflammation modulates the cough response via increased prostaglandin I₂ in ovalbumin-sensitized guinea pigs.
- 1 Jun 2026
- Prostaglandins & other lipid mediators
Guggulsterone-Mediated Selective Modulation of Nuclear Receptors: Implications for FXR-PXR Signaling and Hepatic Metabolic Homeostasis.
- 14 May 2026
- Prostaglandins & other lipid mediators
Effect of essential fatty acids (EFAs) and their metabolites on the growth suppressive action of anti-cancer drug doxorubicin on neuro- and glioblastoma cells in vitro.
- 13 May 2026
- Prostaglandins & other lipid mediators
Pharmacological modulation of NF-κB-dependent COX-2/PGE₂ signaling influences inflammatory lesion development during Leishmania mexicana infection.
- 22 Apr 2026
- Prostaglandins & other lipid mediators
FAQs on Prostaglandins and Other Lipid Mediators
How long has Prostaglandins and Other Lipid Mediators been actively publishing? 
What is the publishing frequency of Prostaglandins and Other Lipid Mediators?
How many articles did Prostaglandins and Other Lipid Mediators publish last year?
What is the eISSN & pISSN for Prostaglandins and Other Lipid Mediators?
What is Citescore for Prostaglandins and Other Lipid Mediators?
What is SNIP score for Prostaglandins and Other Lipid Mediators?
What is the SJR for Prostaglandins and Other Lipid Mediators?
Who is the publisher of Prostaglandins and Other Lipid Mediators?
